IBDEI1QD.m

IBDEI1QD ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,27659,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27659,1,3,0)

 ;;=3^Neuroleptic-Induced Parkinsonism

 ;;^UTILITY(U,$J,358.3,27659,1,4,0)

 ;;=4^G21.11

 ;;^UTILITY(U,$J,358.3,27659,2)

 ;;=^5003772

 ;;^UTILITY(U,$J,358.3,27660,0)

 ;;=G24.01^^113^1347^15

 ;;^UTILITY(U,$J,358.3,27660,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27660,1,3,0)

 ;;=3^Tardive Dyskinesia

 ;;^UTILITY(U,$J,358.3,27660,1,4,0)

 ;;=4^G24.01

 ;;^UTILITY(U,$J,358.3,27660,2)

 ;;=^5003784

 ;;^UTILITY(U,$J,358.3,27661,0)

 ;;=G24.09^^113^1347^16

 ;;^UTILITY(U,$J,358.3,27661,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27661,1,3,0)

 ;;=3^Tardive Dystonia

 ;;^UTILITY(U,$J,358.3,27661,1,4,0)

 ;;=4^G24.09

 ;;^UTILITY(U,$J,358.3,27661,2)

 ;;=^5003786

 ;;^UTILITY(U,$J,358.3,27662,0)

 ;;=G25.1^^113^1347^11

 ;;^UTILITY(U,$J,358.3,27662,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27662,1,3,0)

 ;;=3^Medication-Induced Postural Tremor

 ;;^UTILITY(U,$J,358.3,27662,1,4,0)

 ;;=4^G25.1

 ;;^UTILITY(U,$J,358.3,27662,2)

 ;;=^5003792

 ;;^UTILITY(U,$J,358.3,27663,0)

 ;;=G25.71^^113^1347^14

 ;;^UTILITY(U,$J,358.3,27663,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27663,1,3,0)

 ;;=3^Tardive Akathisia

 ;;^UTILITY(U,$J,358.3,27663,1,4,0)

 ;;=4^G25.71

 ;;^UTILITY(U,$J,358.3,27663,2)

 ;;=^5003799

 ;;^UTILITY(U,$J,358.3,27664,0)

 ;;=G25.79^^113^1347^9

 ;;^UTILITY(U,$J,358.3,27664,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27664,1,3,0)

 ;;=3^Medication-Induced Movement Disorder,Other

 ;;^UTILITY(U,$J,358.3,27664,1,4,0)

 ;;=4^G25.79

 ;;^UTILITY(U,$J,358.3,27664,2)

 ;;=^5003800

 ;;^UTILITY(U,$J,358.3,27665,0)

 ;;=T43.205A^^113^1347^4

 ;;^UTILITY(U,$J,358.3,27665,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27665,1,3,0)

 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr

 ;;^UTILITY(U,$J,358.3,27665,1,4,0)

 ;;=4^T43.205A

 ;;^UTILITY(U,$J,358.3,27665,2)

 ;;=^5050540

 ;;^UTILITY(U,$J,358.3,27666,0)

 ;;=T43.205D^^113^1347^5

 ;;^UTILITY(U,$J,358.3,27666,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27666,1,3,0)

 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr

 ;;^UTILITY(U,$J,358.3,27666,1,4,0)

 ;;=4^T43.205D

 ;;^UTILITY(U,$J,358.3,27666,2)

 ;;=^5050541

 ;;^UTILITY(U,$J,358.3,27667,0)

 ;;=T43.205S^^113^1347^6

 ;;^UTILITY(U,$J,358.3,27667,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27667,1,3,0)

 ;;=3^Antidepressant Discontinuation Syndrome,Sequela

 ;;^UTILITY(U,$J,358.3,27667,1,4,0)

 ;;=4^T43.205S

 ;;^UTILITY(U,$J,358.3,27667,2)

 ;;=^5050542

 ;;^UTILITY(U,$J,358.3,27668,0)

 ;;=G25.71^^113^1347^7

 ;;^UTILITY(U,$J,358.3,27668,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27668,1,3,0)

 ;;=3^Medication-Induced Acute Akathisia

 ;;^UTILITY(U,$J,358.3,27668,1,4,0)

 ;;=4^G25.71

 ;;^UTILITY(U,$J,358.3,27668,2)

 ;;=^5003799

 ;;^UTILITY(U,$J,358.3,27669,0)

 ;;=G24.02^^113^1347^8

 ;;^UTILITY(U,$J,358.3,27669,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27669,1,3,0)

 ;;=3^Medication-Induced Acute Dystonia

 ;;^UTILITY(U,$J,358.3,27669,1,4,0)

 ;;=4^G24.02

 ;;^UTILITY(U,$J,358.3,27669,2)

 ;;=^5003785

 ;;^UTILITY(U,$J,358.3,27670,0)

 ;;=G21.0^^113^1347^12

 ;;^UTILITY(U,$J,358.3,27670,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,27670,1,3,0)

 ;;=3^Neuroleptic Malignant Syndrome

 ;;^UTILITY(U,$J,358.3,27670,1,4,0)

 ;;=4^G21.0

 ;;^UTILITY(U,$J,358.3,27670,2)

 ;;=^5003771

 ;;^UTILITY(U,$J,358.3,27671,0)

 ;;=T50.905A^^113^1347^1

 ;;^UTILITY(U,$J,358.3,27671,1,0)

 ;;=^358.31IA^4^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI1QD   3780     printed  Mar 13, 2025@21:18:31                                                                                                                                                                                                    Page 2

IBDEI1QD  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,27659,1,0)

 +2       ;;=^358.31IA^4^2

 +3       ;;^UTILITY(U,$J,358.3,27659,1,3,0)

 +4       ;;=3^Neuroleptic-Induced Parkinsonism

 +5       ;;^UTILITY(U,$J,358.3,27659,1,4,0)

 +6       ;;=4^G21.11

 +7       ;;^UTILITY(U,$J,358.3,27659,2)

 +8       ;;=^5003772

 +9       ;;^UTILITY(U,$J,358.3,27660,0)

 +10      ;;=G24.01^^113^1347^15

 +11      ;;^UTILITY(U,$J,358.3,27660,1,0)

 +12      ;;=^358.31IA^4^2

 +13      ;;^UTILITY(U,$J,358.3,27660,1,3,0)

 +14      ;;=3^Tardive Dyskinesia

 +15      ;;^UTILITY(U,$J,358.3,27660,1,4,0)

 +16      ;;=4^G24.01

 +17      ;;^UTILITY(U,$J,358.3,27660,2)

 +18      ;;=^5003784

 +19      ;;^UTILITY(U,$J,358.3,27661,0)

 +20      ;;=G24.09^^113^1347^16

 +21      ;;^UTILITY(U,$J,358.3,27661,1,0)

 +22      ;;=^358.31IA^4^2

 +23      ;;^UTILITY(U,$J,358.3,27661,1,3,0)

 +24      ;;=3^Tardive Dystonia

 +25      ;;^UTILITY(U,$J,358.3,27661,1,4,0)

 +26      ;;=4^G24.09

 +27      ;;^UTILITY(U,$J,358.3,27661,2)

 +28      ;;=^5003786

 +29      ;;^UTILITY(U,$J,358.3,27662,0)

 +30      ;;=G25.1^^113^1347^11

 +31      ;;^UTILITY(U,$J,358.3,27662,1,0)

 +32      ;;=^358.31IA^4^2

 +33      ;;^UTILITY(U,$J,358.3,27662,1,3,0)

 +34      ;;=3^Medication-Induced Postural Tremor

 +35      ;;^UTILITY(U,$J,358.3,27662,1,4,0)

 +36      ;;=4^G25.1

 +37      ;;^UTILITY(U,$J,358.3,27662,2)

 +38      ;;=^5003792

 +39      ;;^UTILITY(U,$J,358.3,27663,0)

 +40      ;;=G25.71^^113^1347^14

 +41      ;;^UTILITY(U,$J,358.3,27663,1,0)

 +42      ;;=^358.31IA^4^2

 +43      ;;^UTILITY(U,$J,358.3,27663,1,3,0)

 +44      ;;=3^Tardive Akathisia

 +45      ;;^UTILITY(U,$J,358.3,27663,1,4,0)

 +46      ;;=4^G25.71

 +47      ;;^UTILITY(U,$J,358.3,27663,2)

 +48      ;;=^5003799

 +49      ;;^UTILITY(U,$J,358.3,27664,0)

 +50      ;;=G25.79^^113^1347^9

 +51      ;;^UTILITY(U,$J,358.3,27664,1,0)

 +52      ;;=^358.31IA^4^2

 +53      ;;^UTILITY(U,$J,358.3,27664,1,3,0)

 +54      ;;=3^Medication-Induced Movement Disorder,Other

 +55      ;;^UTILITY(U,$J,358.3,27664,1,4,0)

 +56      ;;=4^G25.79

 +57      ;;^UTILITY(U,$J,358.3,27664,2)

 +58      ;;=^5003800

 +59      ;;^UTILITY(U,$J,358.3,27665,0)

 +60      ;;=T43.205A^^113^1347^4

 +61      ;;^UTILITY(U,$J,358.3,27665,1,0)

 +62      ;;=^358.31IA^4^2

 +63      ;;^UTILITY(U,$J,358.3,27665,1,3,0)

 +64      ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr

 +65      ;;^UTILITY(U,$J,358.3,27665,1,4,0)

 +66      ;;=4^T43.205A

 +67      ;;^UTILITY(U,$J,358.3,27665,2)

 +68      ;;=^5050540

 +69      ;;^UTILITY(U,$J,358.3,27666,0)

 +70      ;;=T43.205D^^113^1347^5

 +71      ;;^UTILITY(U,$J,358.3,27666,1,0)

 +72      ;;=^358.31IA^4^2

 +73      ;;^UTILITY(U,$J,358.3,27666,1,3,0)

 +74      ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr

 +75      ;;^UTILITY(U,$J,358.3,27666,1,4,0)

 +76      ;;=4^T43.205D

 +77      ;;^UTILITY(U,$J,358.3,27666,2)

 +78      ;;=^5050541

 +79      ;;^UTILITY(U,$J,358.3,27667,0)

 +80      ;;=T43.205S^^113^1347^6

 +81      ;;^UTILITY(U,$J,358.3,27667,1,0)

 +82      ;;=^358.31IA^4^2

 +83      ;;^UTILITY(U,$J,358.3,27667,1,3,0)

 +84      ;;=3^Antidepressant Discontinuation Syndrome,Sequela

 +85      ;;^UTILITY(U,$J,358.3,27667,1,4,0)

 +86      ;;=4^T43.205S

 +87      ;;^UTILITY(U,$J,358.3,27667,2)

 +88      ;;=^5050542

 +89      ;;^UTILITY(U,$J,358.3,27668,0)

 +90      ;;=G25.71^^113^1347^7

 +91      ;;^UTILITY(U,$J,358.3,27668,1,0)

 +92      ;;=^358.31IA^4^2

 +93      ;;^UTILITY(U,$J,358.3,27668,1,3,0)

 +94      ;;=3^Medication-Induced Acute Akathisia

 +95      ;;^UTILITY(U,$J,358.3,27668,1,4,0)

 +96      ;;=4^G25.71

 +97      ;;^UTILITY(U,$J,358.3,27668,2)

 +98      ;;=^5003799

 +99      ;;^UTILITY(U,$J,358.3,27669,0)

 +100     ;;=G24.02^^113^1347^8

 +101     ;;^UTILITY(U,$J,358.3,27669,1,0)

 +102     ;;=^358.31IA^4^2

 +103     ;;^UTILITY(U,$J,358.3,27669,1,3,0)

 +104     ;;=3^Medication-Induced Acute Dystonia

 +105     ;;^UTILITY(U,$J,358.3,27669,1,4,0)

 +106     ;;=4^G24.02

 +107     ;;^UTILITY(U,$J,358.3,27669,2)

 +108     ;;=^5003785

 +109     ;;^UTILITY(U,$J,358.3,27670,0)

 +110     ;;=G21.0^^113^1347^12

 +111     ;;^UTILITY(U,$J,358.3,27670,1,0)

 +112     ;;=^358.31IA^4^2

 +113     ;;^UTILITY(U,$J,358.3,27670,1,3,0)

 +114     ;;=3^Neuroleptic Malignant Syndrome

 +115     ;;^UTILITY(U,$J,358.3,27670,1,4,0)

 +116     ;;=4^G21.0

 +117     ;;^UTILITY(U,$J,358.3,27670,2)

 +118     ;;=^5003771

 +119     ;;^UTILITY(U,$J,358.3,27671,0)

 +120     ;;=T50.905A^^113^1347^1

 +121     ;;^UTILITY(U,$J,358.3,27671,1,0)

 +122     ;;=^358.31IA^4^2